Aemetis, Inc. (NASDAQ:AMTX) Given Average Rating of “Moderate Buy” by Analysts

Shares of Aemetis, Inc. (NASDAQ:AMTXGet Free Report) have earned a consensus recommendation of “Moderate Buy” from the five brokerages that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $12.95.

Several analysts have commented on AMTX shares. StockNews.com raised Aemetis to a “sell” rating in a report on Monday. HC Wainwright reiterated a “buy” rating and set a $28.00 target price on shares of Aemetis in a research report on Monday, December 23rd.

Get Our Latest Research Report on Aemetis

Aemetis Stock Performance

Shares of NASDAQ AMTX opened at $2.30 on Friday. The company has a market capitalization of $114.40 million, a PE ratio of -1.02 and a beta of 1.47. The company’s fifty day moving average price is $2.96 and its 200 day moving average price is $2.90. Aemetis has a 1 year low of $2.04 and a 1 year high of $7.03.

Aemetis (NASDAQ:AMTXGet Free Report) last posted its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.47) by $0.09. The firm had revenue of $81.44 million for the quarter, compared to analysts’ expectations of $77.79 million. During the same period in the previous year, the company earned ($0.59) earnings per share. On average, equities analysts expect that Aemetis will post -2.07 EPS for the current year.

Institutional Investors Weigh In On Aemetis

A number of large investors have recently modified their holdings of the business. Clear Harbor Asset Management LLC acquired a new stake in Aemetis in the 4th quarter valued at about $44,000. FMR LLC grew its position in shares of Aemetis by 68.2% in the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after purchasing an additional 9,137 shares in the last quarter. SG Americas Securities LLC purchased a new stake in shares of Aemetis in the fourth quarter valued at approximately $87,000. Barclays PLC increased its holdings in shares of Aemetis by 274.6% in the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock valued at $109,000 after purchasing an additional 34,816 shares during the last quarter. Finally, Wellington Management Group LLP acquired a new position in Aemetis during the third quarter worth $177,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

(Get Free Report

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.

Featured Stories

Analyst Recommendations for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.